Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

2, 6-diamino- pyrimidin- 5-yl-carboxamides as SYK or JAK kinases inhibitors

A compound, amino technology, applied in the preparation of the compound described in this article, the treatment of the disease field characterized by other indications, can solve problems such as Src kinase inactivity

Active Publication Date: 2011-05-18
PORTOLA PHARMA INC
View PDF26 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Interestingly, this ATP-competitive inhibitor of Syk is also active against Flt3, cKit and JAK kinases, but not against Src kinase (Braselmann, Taylor et al., 2006)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 2, 6-diamino- pyrimidin- 5-yl-carboxamides as SYK or JAK kinases inhibitors
  • 2, 6-diamino- pyrimidin- 5-yl-carboxamides as SYK or JAK kinases inhibitors
  • 2, 6-diamino- pyrimidin- 5-yl-carboxamides as SYK or JAK kinases inhibitors

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0309] a. Compound

[0310] In one group of embodiments, the present invention provides a compound having formula (I), a tautomer or a pharmaceutically acceptable salt thereof:

[0311]

[0312] in:

[0313] Y 1 selected from:

[0314]

[0315] Z is O or S;

[0316] D. 1 selected from:

[0317] (a) By group R 5 Substituted phenyl, wherein phenyl is also optionally substituted by 1-2 substituents R 7a replace, R 7a Independently selected from C 1-8 Alkyl, C 1-8 Alkoxy, halo, C 1-8 Alkylsulfonyl and heterocyclyl;

[0318] R 5 selected from:

[0319] (i) heteroaryl;

[0320] (ii) heterocyclyl;

[0321] (iii)C 1-8 Alkylheterocyclyl;

[0322] (iv) phenylene heteroaryl

[0323] (v) phenylene heterocyclyl

[0324] (vi)-L-phenyl;

[0325] (vii)-L-heterocyclyl; and

[0326] (viii) acyloxy;

[0327] L is selected from -CO-, -O-, -SO 2 -, -CONH- and -CONHCH 2 -;

[0328] Each R 5 is optionally further substituted with 1-2 substituents independently selected ...

Embodiment 1

[0640] Example 1: 4-(4-(4-acetylpiperazin-1-yl)anilino)-2-((1R,2S)-2-aminocyclohexylamino)pyrimidine-5-carboxamide

[0641]

[0642] Step 1: To a solution of carboxylic acid 72.1 (85 g, 540 mmol) in thionyl chloride (425 mL) was slowly added pyridine (8.5 mL, 0.11 mmol) with stirring. The reaction was stirred overnight at 75 °C, then concentrated and dried in vacuo to a pale yellow powder. The yellow solid was slowly diluted with 750 mL of ethanol and refluxed overnight. The next day, the reaction was determined to be complete by HPLC, then cooled in an ice bath, and the solid was filtered and washed with ether to afford the ethyl ester 72.2 as an off-white powder (91 g, 87% for two steps). C 7 h 8 N 2 o 4 The MS measured value is (M+H) + 185.0.

[0643] Step 2: Ester 72.2 (22 g, 120 mmol) was dissolved in phosphorus oxychloride (60 mL, 600 mmol), the mixture was treated with N,N-diethylaniline (27 mL, 167 mmol), the mixture was heated to 105 °C until the reaction wa...

Embodiment 2

[0648] Example 2: 2-((1R,2S)-2-aminocyclohexylamino)-4-(4-(1,1-dioxo)thiomorpholineanilino)pyrimidine-5-carboxamide

[0649]

[0650] Using the same synthetic scheme shown in Example 1, substituting 4-(1,1-dioxo)thiomorpholine aniline for aniline 72.4, the above racemic compound was prepared. C 21 h 29 N 7 o 3 The MS measured value of S is (M+H) + 460.2. UVλ=236, 312nm.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention is directed to compounds of formula I-V and tautomers thereof or pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of syk kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition syk kinase activity, methods ofinhibilion the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by syk kinase activity, such as cardiovascular disease, inflammatory disease and autoimmune disease and cell proliferative disorder. Formula (I) Y1 is selected from the group consisting of: (a) and (b); Z is O or S; D1 is selected from the group consisting of: (a) phenyl substituted with a group, R5 (b) naphthyl (c) C3-8cycloalkyl (d) heteroaryl (e) heterocyclyl.

Description

[0001] Cross References to Related Applications [0002] This application claims U.S. Provisional Patent Application No. 61 / 120,348, filed December 5, 2008, U.S. Provisional Patent Application No. 61 / 120,346, filed December 5, 2008, U.S. Provisional Patent Application No. Patent Application No. 61 / 045,406 and the benefit of US Provisional Patent Application No. 61 / 045,499, filed April 16, 2008, the entire contents of which are incorporated herein by reference. technical field [0003] The present invention relates to pyrimidine-5-carboxamide compounds useful as spleen tyrosine kinase (syk) and / or JAK kinase inhibitors. The present invention also relates to pharmaceutical compositions comprising pyrimidine-5-carboxamide compounds, and methods of using the compounds or compositions to treat conditions characterized by other indications. The present invention also relates to methods of preparing the compounds described herein. Background technique [0004] Protein kinases con...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D239/48C07D401/12C07D403/12C07D413/12C07D417/12A61P35/00A61P9/00A61K31/506C07D407/12C07D409/12
CPCC07D401/12C07D403/12C07D409/12C07D417/12C07D407/12C07D413/12C07D239/48C07D405/14A61K31/506A61P3/10A61P7/00A61P7/02A61P7/04A61P7/06A61P9/00A61P9/10A61P11/00A61P11/06A61P13/12A61P17/00A61P17/06A61P19/02A61P25/00A61P29/00A61P35/00A61P35/02A61P37/02A61P37/06A61P37/08A61P43/00C07D471/04C07D487/04A61K45/06A61K2300/00
Inventor Z·J·贾C·文卡塔拉曼尼黄沃林M·梅赫罗特拉宋永红徐亲S·M·鲍尔A·潘迪J·W·罗斯B·凯恩
Owner PORTOLA PHARMA INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com